| Line Item | 2026-01-30 | Y/Y |
|---|---|---|
| Revenue | $113.54B | +18.8% |
| Cost of Revenue | $90.83B | +22.2% |
| Gross Profit | $22.71B | +6.9% |
| R&D Expense | $3.14B | +2.6% |
| SG&A Expense | $11.42B | -4.5% |
| Operating Income | $8.15B | +30.7% |
| Pre-tax Income | $7.26B | +43.9% |
| Income Tax | $1.33B | +181.1% |
| Net Income | $5.94B | +29.3% |
| EPS (Basic) | $8.79 | +35.0% |
| EPS (Diluted) | $8.68 | +36.1% |
| Line Item | 2026-01-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.53B | +217.3% |
| Accounts Receivable | $17.59B | +70.8% |
| Inventory | $10.44B | +55.4% |
| Current Assets | $57.60B | +59.0% |
| Total Assets | $101.29B | +27.0% |
| Current Liabilities | $63.27B | +36.0% |
| Long-term Debt | $31.50B | +28.2% |
| Total Liabilities |
| Line Item | 2026-01-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.19B | +147.4% |
| Capital Expenditures | $2.63B | -0.7% |
| Investing Cash Flow | -$2.06B | +7.2% |
| Financing Cash Flow | -$1.46B | +74.8% |
| Free Cash Flow | $8.55B | +357.6% |
| $103.76B |
| +27.9% |
| Stockholders' Equity | -$2.47B | -66.7% |